Healthy volunteers test new drug ENX-104 in Early-Stage study
NCT ID NCT07472361
First seen Mar 28, 2026 · Last updated Apr 29, 2026 · Updated 2 times
Summary
This early-stage study tested a single dose of the experimental drug ENX-104 in 12 healthy adults. Researchers compared how the drug is absorbed when given as a liquid or a tablet, and whether a high-fat meal changes absorption. The goal was to gather safety and drug-level data, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Parexel London EPCU
Middlesex, London, HA1 3UJ, United Kingdom
Conditions
Explore the condition pages connected to this study.